NKTX
Price
$2.66
Change
+$0.19 (+7.69%)
Updated
Aug 21 closing price
Capitalization
190.52M
80 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.50
Change
+$0.16 (+4.79%)
Updated
Aug 21 closing price
Capitalization
1.9B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NKTX vs RXRX

NKTX vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
NKTX vs. RXRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (NKTX: $2.66 vs. RXRX: $3.50)
Brand notoriety: NKTX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 171% vs. RXRX: 86%
Market capitalization -- NKTX: $190.52M vs. RXRX: $1.9B
NKTX [@Biotechnology] is valued at $190.52M. RXRX’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NKTX and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 7 bullish TA indicator(s).

  • NKTX’s TA Score: 5 bullish, 5 bearish.
  • RXRX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than NKTX.

Price Growth

NKTX (@Biotechnology) experienced а +14.16% price change this week, while RXRX (@Biotechnology) price change was +10.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

NKTX is expected to report earnings on Nov 11, 2026.

RXRX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.9B) has a higher market cap than NKTX($191M). NKTX YTD gains are higher at: 43.784 vs. RXRX (-14.425). NKTX has higher annual earnings (EBITDA): -107.08M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. NKTX (230M). RXRX (72.4M) and NKTX (75M) have identical debt. RXRX has higher revenues than NKTX: RXRX (65.7M) vs NKTX (0).
NKTXRXRXNKTX / RXRX
Capitalization191M1.9B10%
EBITDA-107.08M-478.66M22%
Gain YTD43.784-14.425-304%
P/E RatioN/AN/A-
Revenue065.7M-
Total Cash230M654M35%
Total Debt75M72.4M104%
FUNDAMENTALS RATINGS
NKTX: Fundamental Ratings
NKTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
NKTX
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXW49.001.71
+3.62%
Roundhill Gold Miners Weeklypay ETF
RISR36.850.12
+0.33%
FolioBeyond Alt Inc and Int Rt Hdg ETF
GGM31.74N/A
N/A
GGM Macro Alignment ETF
RTXG23.76N/A
N/A
Leverage Shares 2X Long Rtx Daily ETF
RAVI75.33-0.04
-0.05%
Northern Trust Ultra-Short Fixed Inc ETF

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with EDIT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+7.69%
EDIT - NKTX
52%
Loosely correlated
+5.78%
RXRX - NKTX
49%
Loosely correlated
+4.79%
PRME - NKTX
49%
Loosely correlated
+4.63%
VIR - NKTX
47%
Loosely correlated
+6.19%
RCKT - NKTX
47%
Loosely correlated
+0.86%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with PRME. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+4.79%
PRME - RXRX
63%
Loosely correlated
+4.63%
CRSP - RXRX
62%
Loosely correlated
+2.37%
ABSI - RXRX
61%
Loosely correlated
+2.91%
ABCL - RXRX
59%
Loosely correlated
-2.16%
BEAM - RXRX
57%
Loosely correlated
+4.83%
More